Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at AS

[News]

Celsion Corporation announced today that an abstract on the Phase I/II DIGNITY trial of ThermoDox in Recurrent Chest Wall Breast Cancer has been accepted for a poster session at the 52nd American Society for Radiation Oncology Annual Meeting. The abstract will provide updated clinical results, as well as the rationale and design of the DIGNITY study, which is evaluating ThermoDox in combination with microwave hyperthermia in women with RCW Breast Cancer.

More... (http://www.news-medical.net/news/20100614/Abstract-on-Phase-III-DIGNITY-trial-of-ThermoDox-in-RCW-Breast-Cancer-accepted-at-ASTRO-2010.aspx)